methyl 3-((1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)-5-phenylthiophene-2-carboxylate

Catalog No. :
ACHFDR014
CAS No. :
-
Molecular Formula :
C25H22N4O5S
Molecular Weight :
490.54

IUPAC Name:methyl 3-((1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)-5-phenylthiophene-2-carboxylate

methyl 3-((1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)-5-phenylthiophene-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$358.00Login to see priceInquiryInquiry
250mg95%$715.00Login to see priceInquiryInquiry
1g95%$1525.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 3-((1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)-5-phenylthiophene-2-carboxylate
IUPAC Namemethyl 3-((1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)amino)-5-phenylthiophene-2-carboxylate
Molecular FormulaC25H22N4O5S
Molecular Weight490.54
SMILESCOC(=O)C1=C(NC2=CC=C3C(=C2)N(C)C(=O)N3C2CCC(=O)NC2=O)C=C(C2=CC=CC=C2)S1
InChI KeyWGSCAZOCTNUURN-UHFFFAOYSA-N

Synthetic Route by SureRoute

1. ACHFDR014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFXK521 route compound structure diagram
    ACNFXK521100063-22-7 In Stock
  2. Plus
  3. ACIJSZ789 route compound structure diagram
    ACIJSZ7892300099-98-1 In Stock
  4. Then
  5. ACHFDR014 route product structure diagram
    ACHFDR014-
Inquiry

2. ACHFDR014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFXK521 route compound structure diagram
    ACNFXK521100063-22-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHFDR014 route product structure diagram
    ACHFDR014-
Inquiry

Comments (0)